Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. Rosenwald

Clinical Impact of Recurrently Mutated Genes on Lymphoma Diagnostics: State-Of-The-Art and Beyond

Haematologica

Hematology

2016

English

Clinical Activity of Regn1979, an Anti-Cd20 X Anti-Cd3 Bispecific Antibody (Ab) in Patients (Pts) With (W/) Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-Nhl)

Hematological Oncology

English

Foxp1 Expression Is Inversely Correlated With Ezh2 Mutation Status and Predicts Poor Failure-Free Survival in Follicular Lymphoma Treated With Rituximab and Chemotherapy

Hematological Oncology

English

P53 but Not Sox11 Ihc Has Prognostic Value Independent of Mipi and Ki-67 in Prospective Trials of the European-MCL Network

Hematological Oncology

English

Ebeacopp With or Without Rituximab in Interim-Pet-Positive Advanced-Stage Hodgkin Lymphoma: Updated Results of the International, Randomized Phase 3 GHSG Hd18 Trial

Hematological Oncology

English

Samd14/Neurabin-I as BCR-Antigens of Primary Central Nervous System Lymphoma

Hematological Oncology

English

INTENSIVE IMMUNOCHEMOTHERAPY (R-Choep) VS HIGH-DOSE IMMUNOCHEMOTHERAPY (R-MegaCHOEP) IN YOUNG PATIENTS WITH AGGRESSIVE B-Cell LYMPHOMA: A 10-Year LONG-TERM FOLLOW-UP

Hematological Oncology

English

MicroRNA Expression, Chromosomal Alterations, and Immunoglobulin Variable Heavy Chain Hypermutations in Mantle Cell Lymphomas

Cancer Research

Oncology

2009

English

Rare Occurrence of IgVH Gene Translocations and Restricted IgVH Gene Repertoire in Ocular MALT-type Lymphoma

Haematologica

Hematology

2008

English

Retracted: Immunohistochemical Prognostic Markers in Diffuse Large B-Cell Lymphoma: Validation of Tissue Microarray as a Prerequisite for Broad Clinical Applications (A Study From the Lunenburg Lymphoma Biomarker Consortium)

Journal of Clinical Pathology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. Rosenwald

Clinical Impact of Recurrently Mutated Genes on Lymphoma Diagnostics: State-Of-The-Art and Beyond

Clinical Activity of Regn1979, an Anti-Cd20 X Anti-Cd3 Bispecific Antibody (Ab) in Patients (Pts) With (W/) Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-Nhl)

Foxp1 Expression Is Inversely Correlated With Ezh2 Mutation Status and Predicts Poor Failure-Free Survival in Follicular Lymphoma Treated With Rituximab and Chemotherapy

P53 but Not Sox11 Ihc Has Prognostic Value Independent of Mipi and Ki-67 in Prospective Trials of the European-MCL Network

Ebeacopp With or Without Rituximab in Interim-Pet-Positive Advanced-Stage Hodgkin Lymphoma: Updated Results of the International, Randomized Phase 3 GHSG Hd18 Trial

Samd14/Neurabin-I as BCR-Antigens of Primary Central Nervous System Lymphoma

INTENSIVE IMMUNOCHEMOTHERAPY (R-Choep) VS HIGH-DOSE IMMUNOCHEMOTHERAPY (R-MegaCHOEP) IN YOUNG PATIENTS WITH AGGRESSIVE B-Cell LYMPHOMA: A 10-Year LONG-TERM FOLLOW-UP

MicroRNA Expression, Chromosomal Alterations, and Immunoglobulin Variable Heavy Chain Hypermutations in Mantle Cell Lymphomas

Rare Occurrence of IgVH Gene Translocations and Restricted IgVH Gene Repertoire in Ocular MALT-type Lymphoma

Retracted: Immunohistochemical Prognostic Markers in Diffuse Large B-Cell Lymphoma: Validation of Tissue Microarray as a Prerequisite for Broad Clinical Applications (A Study From the Lunenburg Lymphoma Biomarker Consortium)